Measurement of heart rate variability: a clinical tool or a research toy?

The objectives of this review are to discuss the diversity of mechanisms that may explain the association between heart rate (HR) variability and mortality, to appraise the clinical applicability of traditional and new measures of HR variability and to propose future directions in this field of rese...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology Jg. 34; H. 7; S. 1878
Hauptverfasser: Huikuri, H V, Mäkikallio, T, Airaksinen, K E, Mitrani, R, Castellanos, A, Myerburg, R J
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.12.1999
Schlagworte:
Animals
Cardiovascular Diseases - mortality
Cardiovascular Diseases - physiopathology
Circadian Rhythm - physiology
Death, Sudden, Cardiac - epidemiology
Death, Sudden, Cardiac - prevention & control
Electrocardiography, Ambulatory - methods
Heart Rate - physiology
Humans
Incidence
Prognosis
Survival Rate
ISSN:0735-1097
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The objectives of this review are to discuss the diversity of mechanisms that may explain the association between heart rate (HR) variability and mortality, to appraise the clinical applicability of traditional and new measures of HR variability and to propose future directions in this field of research. There is a large body of data demonstrating that abnormal HR variability measured over a 24-h period provides information on the risk of subsequent death in subjects with and without structural heart disease. However, the mechanisms responsible for this association are not completely established. Therefore, no specific therapy is currently available to improve the prognosis for patients with abnormal HR variability. Reduced HR variability has been most commonly associated with a risk of arrhythmic death, but recent data suggest that abnormal variability also predicts vascular causes of death, progression of coronary atherosclerosis and death due to heart failure. A consensus is also lacking on the best HR variability measure for clinical purposes. Time and frequency domain measures of HR variability have been most commonly used, but recent studies show that new analysis methods based on nonlinear dynamics may be more powerful in terms of risk stratification. Before the measurement of HR variability can be applied to clinical practice and used to direct therapy, more precise insight into the pathophysiological link between HR variability and mortality are needed. Further studies should also address the issue of which of the HR variability indexes, including the new nonlinear measures, is best for clinical purposes in various patient populations.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0735-1097
DOI:10.1016/S0735-1097(99)00468-4